These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1071 related articles for article (PubMed ID: 856354)

  • 41. [Sulfadimezine and sulfamomomethoxine distribution in the body of white rats in single and repeated administration in combination with UV irradiation].
    Matveeva SA
    Farmakol Toksikol; 1979; 42(3):288-91. PubMed ID: 446714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.
    Grant DM; Mörike K; Eichelbaum M; Meyer UA
    J Clin Invest; 1990 Mar; 85(3):968-72. PubMed ID: 2312737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Proliferative activity and cytotoxic effect of mouse lymphocytes during the growth of transplanted melanoma B-16].
    Korosteleva TA; Veresova OV
    Eksp Onkol; 1984; 6(1):53-5. PubMed ID: 6499732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamster.
    Hein DW; Kirlin WG; Ferguson RJ; Weber WW
    J Pharmacol Exp Ther; 1985 Aug; 234(2):358-64. PubMed ID: 3874952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells.
    Ricca A; Biroccio A; Trisciuoglio D; Cippitelli M; Zupi G; Del Bufalo D
    Br J Cancer; 2001 Dec; 85(12):1914-21. PubMed ID: 11747334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. N-acetylation of drugs: isolation and properties of an N-acetyltransferase from rabbit liver.
    Weber WW; Cohen SN
    Mol Pharmacol; 1967 May; 3(3):266-73. PubMed ID: 6037685
    [No Abstract]   [Full Text] [Related]  

  • 49. Sulfonamide acetylation in isolated rabbit and rat liver cells.
    Olsen H; Mørland J; Rothschild MA
    Acta Pharmacol Toxicol (Copenh); 1981 Nov; 49(5):438-46. PubMed ID: 7345886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical evaluation of N-acetyltransferase activity in children with various forms of diffuse connective tissue diseases].
    Ermakova TM; Kovaleva VL; Brezhneva EG; Evstaf'eva OL; Alekseev IuV
    Pediatriia; 1983 Nov; (11):10-3. PubMed ID: 6669424
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of concurrent administration of other substrates of N-acetyltransferase on dapsone acetylation.
    Ahmad RA; Rogers HJ; Vandenburg M; Wright P
    Br J Clin Pharmacol; 1981 Jul; 12(1):83-6. PubMed ID: 7248142
    [No Abstract]   [Full Text] [Related]  

  • 52. N-acetyltransferase activity as a possible criterion in prognosing the anti-tumor effect of cyclophosphamide.
    Bulovskaya LN; Kolosov AI; Krupkin RG
    Oncology; 1979; 36(3):130-3. PubMed ID: 471424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of high-performance liquid chromatography in the measurement of in vitro acetylation in man.
    Baty JD; Lindsay RM; Sharp S
    J Chromatogr; 1986 Feb; 353():329-37. PubMed ID: 3700517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Choline acetyltransferase activity in muscles of old rats.
    Tucek S; Gutmann E
    Exp Neurol; 1973 Mar; 38(3):349-60. PubMed ID: 4696108
    [No Abstract]   [Full Text] [Related]  

  • 55. Coenzyme A and acetylation in various experimental obesities.
    THOMPSON M; MAYER J
    Am J Physiol; 1962 May; 202():1005-10. PubMed ID: 13920911
    [No Abstract]   [Full Text] [Related]  

  • 56. [In vitro inhibition of the acetylating activity of coenzyme A produced by various acetic acid derivatives].
    GARATTINI S; MORPURGO C; PASSERINI N
    G Ital Chemioter; 1955; 2(1-2):60-3. PubMed ID: 13262581
    [No Abstract]   [Full Text] [Related]  

  • 57. [Inhibition of the acetylation function of coenzyme A].
    WAGNER-JAUREGG T
    Experientia; 1957 Jul; 13(7):277-9. PubMed ID: 13461852
    [No Abstract]   [Full Text] [Related]  

  • 58. [Modified method of determination of sulfanilamides with the application of determination of coenzyme A and determination of acetylation capacity of tissues].
    SYTINSKAIA ON
    Vopr Med Khim; 1956; 2(3):214-21. PubMed ID: 13352890
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy of low-molecular-weight heparin and unfractionated heparin to prevent adhesion of human prostate and bladder carcinoma and melanoma cells to bovine endothelial monolayers. An in vitro study and review of the literature.
    Lersch C; Gericke D; Classen M
    Urol Int; 1996; 56(4):230-3. PubMed ID: 8776820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The PTEN tumour suppressor gene and malignant melanoma.
    Böni R; Vortmeyer AO; Burg G; Hofbauer G; Zhuang Z
    Melanoma Res; 1998 Aug; 8(4):300-2. PubMed ID: 9764804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.